Characterization of primary DLBCL cells
DLBCL PS . | Type . | CD10 . | Bcl-6 . | IRF4/MUM-1 . | NF-κB1/2 . |
---|---|---|---|---|---|
1 | GCB | + | + | + | + |
2 | GCB | − | + | − | + |
3 | GCB | + | + | N/A | + |
4 | GCB | − | + | − | + |
5 | GCB | + | + | N/A | + |
6 | GCB | − | + | − | + |
7 | GCB | + | + | − | + |
8 | GCB | + | + | + | + |
9 | GCB | + | + | + | + |
10 | ABC | − | − | + | + |
11 | ABC | − | − | + | + |
12 | ABC | − | − | + | + |
13 | ABC | − | − | + | + |
14 | ABC | − | − | + | + |
DLBCL PS . | Type . | CD10 . | Bcl-6 . | IRF4/MUM-1 . | NF-κB1/2 . |
---|---|---|---|---|---|
1 | GCB | + | + | + | + |
2 | GCB | − | + | − | + |
3 | GCB | + | + | N/A | + |
4 | GCB | − | + | − | + |
5 | GCB | + | + | N/A | + |
6 | GCB | − | + | − | + |
7 | GCB | + | + | − | + |
8 | GCB | + | + | + | + |
9 | GCB | + | + | + | + |
10 | ABC | − | − | + | + |
11 | ABC | − | − | + | + |
12 | ABC | − | − | + | + |
13 | ABC | − | − | + | + |
14 | ABC | − | − | + | + |
Fourteen DLBCL primary samples were used to characterize the expression of bcl-6, CD10, IRF-4 (MUM1), and NF-κB. CD10, bcl-6, and IRF-4 expression was analyzed using immunohistochemistry and Western blot analysis. NF-κB expression was analyzed by DNA-binding ELISA.
+ indicates positive; −, negative; and PS, patient samples.